Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 1
2007 2
2008 3
2009 6
2010 2
2011 2
2012 3
2013 1
2014 4
2015 1
2016 4
2017 2
2018 1
2019 2
2020 6
2021 6
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.
Del Prato S, Kahn SE, Pavo I, Weerakkody GJ, Yang Z, Doupis J, Aizenberg D, Wynne AG, Riesmeyer JS, Heine RJ, Wiese RJ; SURPASS-4 Investigators. Del Prato S, et al. Among authors: doupis j. Lancet. 2021 Nov 13;398(10313):1811-1824. doi: 10.1016/S0140-6736(21)02188-7. Epub 2021 Oct 18. Lancet. 2021. PMID: 34672967 Clinical Trial.
Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial.
Zinman B, Aroda VR, Buse JB, Cariou B, Harris SB, Hoff ST, Pedersen KB, Tarp-Johansen MJ, Araki E; PIONEER 8 Investigators. Zinman B, et al. Diabetes Care. 2019 Dec;42(12):2262-2271. doi: 10.2337/dc19-0898. Epub 2019 Sep 17. Diabetes Care. 2019. PMID: 31530667 Free PMC article. Clinical Trial.
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Brown-Frandsen K, Moses A, Skibsted S, Kvist K, Buse JB; DEVOTE Study Group. Marso SP, et al. N Engl J Med. 2017 Aug 24;377(8):723-732. doi: 10.1056/NEJMoa1615692. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605603 Free PMC article. Clinical Trial.
Managing Diabetes During the COVID-19 Pandemic.
Doupis J, Avramidis K. Doupis J, et al. Eur Endocrinol. 2020 Oct;16(2):85-87. doi: 10.17925/EE.2020.16.2.85. Epub 2020 Oct 6. Eur Endocrinol. 2020. PMID: 33117436 Free PMC article.
Smartphone-Based Technology in Diabetes Management.
Doupis J, Festas G, Tsilivigos C, Efthymiou V, Kokkinos A. Doupis J, et al. Diabetes Ther. 2020 Mar;11(3):607-619. doi: 10.1007/s13300-020-00768-3. Epub 2020 Jan 25. Diabetes Ther. 2020. PMID: 31983028 Free PMC article. Review.
Gestational diabetes from A to Z.
Mirghani Dirar A, Doupis J. Mirghani Dirar A, et al. Among authors: doupis j. World J Diabetes. 2017 Dec 15;8(12):489-511. doi: 10.4239/wjd.v8.i12.489. World J Diabetes. 2017. PMID: 29290922 Free PMC article. Review.
Painful diabetic neuropathy: clinical aspects.
Didangelos T, Doupis J, Veves A. Didangelos T, et al. Among authors: doupis j. Handb Clin Neurol. 2014;126:53-61. doi: 10.1016/B978-0-444-53480-4.00005-9. Handb Clin Neurol. 2014. PMID: 25410214 Review.
Linagliptin: from bench to bedside.
Doupis J. Doupis J. Drug Des Devel Ther. 2014 May 5;8:431-46. doi: 10.2147/DDDT.S59523. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 24851042 Free PMC article. Review.
48 results